# Laboratoire Schmidt-Nagel Inc. – FDA Inspection, Mar 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/laboratoire-schmidt-nagel-inc/3f5ba4fe-21fb-4bb1-bfcd-0209715dee2b
Source feed: FDA_Inspections

> FDA inspection 1088016 of Laboratoire Schmidt-Nagel Inc., March 29, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1088016
- Company Name: Laboratoire Schmidt-Nagel Inc.
- Inspection Date: 2019-03-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1288236 - 2025-08-15
- FDA Inspection 995842 - 2016-12-01

## Related Officers

- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)

Company: https://www.keypedia.com/companies/laboratoire-schmidt-nagel-inc/6746d837-e8ca-47ae-b37b-05eb58896406

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
